Macrogenics (MGNX) Misses Q3 EPS by 19c

Macrogenics (NASDAQ: MGNX) reported Q3 EPS of ($1.28), $0.19 worse than the analyst estimate of ($1.09). Revenue for the quarter came in at $1.66 million versus the consensus estimate of $4.11 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
• MacroGenics (MGNX) PT Raised to $11 at B.Riley